BT-032

N/A

Report date: 2023/05/22 10:20:07
NME

Base Information

Drug NameBT-032
Drug Alias NameBT-032
ClassificationSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsNACHT, LRR and PYD domains-containing protein 1 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 1NACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBacainn Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBacainn Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A